Literature DB >> 7653424

Fibromyalgia: more than just a musculoskeletal disease.

D J Clauw1.   

Abstract

Fibromyalgia is a common condition characterized by diffuse musculoskeletal pain and fatigue. The syndrome is defined by the presence of musculoskeletal tender points on physical examination. Additionally, persons with this syndrome have a high incidence of headaches, ocular and vestibular complaints, paresthesias, esophageal dysmotility, "allergic" symptoms, irritable bowl syndrome, genitourinary symptoms and affective disorders. Recent research has revealed a number of objective biochemical, hormonal and neurotransmitter abnormalities associated with fibromyalgia, making it a clearly identifiable condition. These abnormalities may clarify our understanding of the pathogenesis and treatment of fibromyalgia.

Entities:  

Mesh:

Year:  1995        PMID: 7653424

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  11 in total

1.  Nociceptive aspects of fibromyalgia.

Authors:  A A Larson; K J Kovács
Journal:  Curr Pain Headache Rep       Date:  2001-08

Review 2.  A practical approach to fibromyalgia.

Authors:  Tyler Childs Cymet
Journal:  J Natl Med Assoc       Date:  2003-04       Impact factor: 1.798

Review 3.  The use of complementary medical therapies in the management of myofascial pain disorders.

Authors:  R E Harris; D J Clauw
Journal:  Curr Pain Headache Rep       Date:  2002-10

4.  Urodynamic study and quality of life in patients with fibromyalgia and lower urinary tract symptoms.

Authors:  Maíta Poli de Araújo; Alex Carvalho Faria; Claudia Cristina Takano; Emerson de Oliveira; Marair Gracio Ferreira Sartori; Daniel Feldman Pollak; Manoel Joâo Batista Castello Girão
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-03-04

Review 5.  Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states.

Authors:  H M Bryson; M I Wilde
Journal:  Drugs Aging       Date:  1996-06       Impact factor: 3.923

6.  Effects of Cognitive-Behavioral Therapy (CBT) on Brain Connectivity Supporting Catastrophizing in Fibromyalgia.

Authors:  Asimina Lazaridou; Jieun Kim; Christine M Cahalan; Marco L Loggia; Olivia Franceschelli; Chantal Berna; Peter Schur; Vitaly Napadow; Robert R Edwards
Journal:  Clin J Pain       Date:  2017-03       Impact factor: 3.442

7.  Proinflammatory cytokines and DHEA-S in women with fibromyalgia: impact of psychological distress and menopausal status.

Authors:  John A Sturgeon; Beth D Darnall; Heather L Zwickey; Lisa J Wood; Douglas A Hanes; David T Zava; Sean C Mackey
Journal:  J Pain Res       Date:  2014-12-04       Impact factor: 3.133

8.  Effects of tianeptine on symptoms of fibromyalgia via BDNF signaling in a fibromyalgia animal model.

Authors:  Hwayoung Lee; Jiyun Im; Hansol Won; Wooyoung Nam; Young Ock Kim; Sang Won Lee; Sanghyun Lee; Ik-Hyun Cho; Hyung-Ki Kim; Jun-Tack Kwon; Hak-Jae Kim
Journal:  Korean J Physiol Pharmacol       Date:  2017-06-26       Impact factor: 2.016

9.  General symptom reporting in female fibromyalgia patients and referents: a population-based case-referent study.

Authors:  Karin Björkegren; Mari-Ann Wallander; Saga Johansson; Kurt Svärdsudd
Journal:  BMC Public Health       Date:  2009-10-31       Impact factor: 3.295

10.  Treatment options and patient perspectives in the management of fibromyalgia: future trends.

Authors:  Kim Lawson
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.